Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DD-study: diet or diuretics for salt-sensitivity in chronic kidney disease
2015-003637-96Phase 4Active
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydrochlorothiazide + amiloride in hypertension (HTN) and chronic kidney disease (CKD) (2 arms). Primary endpoint: 24-hour ambulatory blood pressure. Started Sep 2015; status: active.
02
Drugs
hydrochlorothiazide + amiloride
03
Conditions
hypertension (HTN)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2015-003637-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003637-96.